查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1865439

全球益生菌補充劑市場：預測至 2032 年—按成分、劑型、用途、最終用戶、分銷管道和地區進行分析

Probiotic Supplements Market Forecasts to 2032 - Global Analysis By Ingredient, Form, Application, End User, Distribution Channel, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的一項研究，預計 2025 年全球益生菌補充劑市場價值為 88 億美元，到 2032 年將達到 169 億美元。

預計在預測期內，益生菌市場將以9.7%的複合年成長率成長。益生菌補充劑是一種膳食補充劑，含有活性有益細菌和酵母，旨在透過支持腸道微生物群來提供健康益處。在持續的科學研究和針對特定健康狀況（而不僅僅是一般消化功能）的產品創新推動下，隨著消費者越來越意識到腸道健康與免疫系統之間的聯繫，益生菌市場持續穩定成長。

提高消費者對腸道健康的認知

越來越多的科學研究和媒體報導鞏固了益生菌攝取與改善消化功能之間的關聯。這一認知鼓勵消費者積極主動管理腸道健康，將焦點從治療轉向預防。此外，人們對腸腦軸及其對心理健康影響的認知不斷提高，也使得益生菌的消費群不再局限於傳統的消化支持人群，從而顯著推動了不同人群的市場需求和產品普及。

高品質、經臨床研究的益生菌補充劑高成本

高活性益生菌補充劑價格高是市場滲透的一大障礙。高昂的價格源自於大量的研發投入、嚴格的臨床試驗（用於檢驗特定菌株的健康益處）以及複雜的生產流程（以確保細菌在複雜的供應鏈和保存期限內保持活性）。這種定價結構使得許多注重成本的消費者無法負擔這些經過驗證的產品，使他們在與低品質、未經證實的替代品競爭時處於劣勢，並可能限制整個市場的成長，使其主要面向更富裕的消費者。

個性化益生菌的研發

微生物組檢測和數據分析技術的進步為個人化益生菌配方的開發帶來了變革性的機會。這種方法突破了「一刀切」的模式，能夠根據個人獨特的腸道微生物組組成、健康目標和遺傳傾向來客製化補充劑。這種個人化客製化有望提高功效和改善消費者體驗，從而創造一個高價值的細分市場。它還有助於增強品牌忠誠度和實現溢價，使個人化益生菌成為營養科學和消費者保健領域的新前沿。

各國監管環境嚴格且不斷變化

不同地區（包括美國FDA、歐洲EFSA和其他國家機構）對健康聲明的核准、標籤要求和品質標準差異顯著。這些不斷變化的法規可能導致產品上市延遲、合規成本增加以及配方調整的需求。此外，益生菌缺乏統一的監管定義，造成市場混亂和違規風險，對國際擴大策略和製造商的業務穩定性構成持續威脅。

新冠疫情的感染疾病：

疫情初期擾亂了全球供應鏈，導致益生菌市場原料短缺和物流延誤。然而，疫情也成為益生菌市場強勁成長的催化劑，這主要得益於消費者對預防醫學和增強免疫力日益成長的興趣。隨著越來越多的人尋求益生菌補充劑來增強自身免疫力，市場需求顯著飆升。疫情期間，電子商務在保健品購買領域的普及速度加快，腸道健康也成為主流健康議題。即使在疫情結束後，這種行為模式的改變仍對市場擴張產生正面影響。

預計在預測期內，乳酸菌細分市場將佔據最大的市場佔有率。

由於乳桿菌屬擁有悠久的研究歷史，在治療常見消化系統疾病（如大腸激躁症(IBS) 和乳糖不耐受）方面已被證實有效，並且廣泛應用於從膠囊到發酵食品和飲料等各種產品中，預計在預測期內，乳桿菌屬將佔據最大的市場佔有率。此外，消費者對嗜酸乳桿菌和鼠李糖乳桿菌等乳酸桿菌菌株的高度認知和信任，鞏固了其市場主導地位。乳酸桿菌屬的多功能性和良好的安全性預計將持續推動強烈的需求，使其成為益生菌領域消費者和生產商的基石菌屬。

預計在預測期內，免疫健康領域將實現最高的複合年成長率。

預計在預測期內，免疫健康領域將實現最高成長率，這主要得益於疫情後消費者對持續免疫支持的日益重視。大量科學證據表明，健康的腸道菌叢與強大的免疫功能密切相關，這是成長要素。此外，以科學為基礎的功效行銷策略也引起了全球注重健康的消費者的共鳴。消費者意識的提升、臨床檢驗以及針對性的產品開發共同構成了強大的成長動力。

佔比最大的地區：

預計北美將在整個預測期內佔據最大的市場佔有率。這一優勢得益於消費者較高的健康意識、可支配收入以及完善的膳食補充劑零售和電子商務基礎設施。主要市場參與者的存在以及積極尋求預防性醫療保健解決方案的消費群進一步鞏固了其市場地位。此外，儘管監管標準嚴格，但該地區清晰的市場通路以及消費者對高階健康產品的投資意願，確保了其持續的收入主導地位。

複合年成長率最高的地區：

預計亞太地區在預測期內將實現最高的複合年成長率。這一加速成長主要得益於不斷壯大的中產階級及其可支配收入的增加、快速的都市化以及人們對預防性醫療保健日益成長的重視。此外，人們對腸道健康益處的認知不斷提高、傳統發酵食品對區域飲食文化的影響，以及國內外保健品公司積極拓展新興市場，也是關鍵的成長要素。這種充滿活力的環境使亞太地區成為未來市場擴張的焦點。

免費客製化服務

訂閱本報告的用戶可從以下免費自訂選項中選擇一項：

  • 公司簡介
    • 對最多三家其他公司進行全面分析
    • 對主要企業進行SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶興趣對主要國家進行市場估算、預測和複合年成長率分析（註：基於可行性檢查）
  • 競爭基準化分析
    • 基於產品系列、地域覆蓋和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 引言

  • 概述
  • 相關利益者
  • 分析範圍
  • 分析方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 分析方法
  • 分析材料
    • 原始研究資料
    • 二手研究資訊來源
    • 先決條件

第3章 市場趨勢分析

  • 介紹
  • 促進要素
  • 抑制因素
  • 市場機遇
  • 威脅
  • 應用分析
  • 終端用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代產品的威脅
  • 新參與企業的威脅
  • 公司間的競爭

5. 全球益生菌補充劑市場（按成分分類）

  • 介紹
  • 乳酸菌
  • 雙歧桿菌
  • 嗜熱鏈球菌
  • 布拉氏酵母
  • 其他菌株

6. 全球益生菌補充劑市場（以劑型分類）

  • 介紹
  • 膠囊和片劑
  • 粉末
  • 液體
  • 軟糖/咀嚼片

7. 全球益生菌補充劑市場（按應用分類）

  • 介紹
  • 消化器官系統健康
  • 免疫健康
  • 免疫健康
  • 口腔健康
  • 體重管理
  • 其他用途

8. 全球益生菌補充劑市場（按最終用戶分類）

  • 介紹
  • 成人
  • 嬰幼兒
  • 老年人

9. 全球益生菌補充劑市場（按分銷管道分類）

  • 介紹
  • 大賣場/超級市場
  • 藥房和藥品商店
  • 專賣店
  • 線上零售/電子商務
  • 直銷

第10章 全球益生菌補充劑市場（按地區分類）

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章：主要趨勢

  • 合約、商業夥伴關係和合資企業
  • 企業合併（M&A）
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第12章：公司簡介

  • Chr. Hansen A/S
  • Probi AB
  • Yakult Honsha Co., Ltd.
  • Nestle SA
  • Danone SA
  • International Flavors & Fragrances Inc.（IFF）
  • Lallemand Inc.
  • BioGaia AB
  • Kerry Group plc
  • Glanbia plc
  • NOW Health Group, Inc.
  • Herbalife Nutrition Ltd.
  • Amway Corp.
  • Kemin Industries, Inc.
  • Jarrow Formulas, Inc.
  • Seed Health, Inc.
  • Bio-K Plus International Inc.
  • GNC Holdings, LLC
Product Code: SMRC32211

According to Stratistics MRC, the Global Probiotic Supplements Market is accounted for $8.8 billion in 2025 and is expected to reach $16.9 billion by 2032, growing at a CAGR of 9.7% during the forecast period. Probiotic Supplements includes dietary supplements containing live beneficial bacteria and yeasts intended to confer a health benefit by supporting the gut microbiome. It is growing steadily as consumer awareness of the gut-health-immune system connection deepens, supported by ongoing scientific research and product innovation targeting specific health conditions beyond general digestion.

Market Dynamics:

Driver:

Growing consumer awareness of gut health

Increased scientific research and media coverage have solidified the link between probiotic consumption and improved digestive function. This knowledge is driving consumers to proactively manage their gut health, shifting from treatment to prevention. Furthermore, the broadening recognition of the gut-brain axis and its impact on mental well-being is expanding the consumer base beyond traditional digestive aid seekers, thereby significantly boosting market demand and product adoption across diverse demographics.

Restraint:

High cost of high-quality, clinically-studied probiotic supplements

A significant barrier to wider market penetration is the premium price of high-efficacy probiotic supplements. These costs are attributable to extensive research and development, rigorous clinical trials to validate strain-specific health claims, and advanced manufacturing processes that ensure bacterial viability through complex supply chains and shelf life. This pricing structure places these proven products out of reach for a substantial portion of cost-sensitive consumers. Consequently, it creates a competitive disadvantage against lower-quality, unsubstantiated alternatives, potentially limiting overall market growth to more affluent segments.

Opportunity:

Expansion into personalized probiotics

A transformative opportunity lies in the development of personalized probiotic formulations, driven by advancements in microbiome testing and data analytics. This approach allows for supplements tailored to an individual's unique gut flora composition, health goals, and genetic predispositions, moving beyond a one-size-fits-all model. Such customization promises enhanced efficacy and consumer outcomes, creating a high-value market segment. Moreover, it fosters stronger brand loyalty and enables companies to command premium pricing, positioning personalized probiotics as the next frontier in nutritional science and consumer healthcare.

Threat:

Stringent and evolving regulatory landscapes across different countries

Health claim approvals, labeling requirements, and quality standards vary significantly between regions like the FDA in the U.S., EFSA in Europe, and other national bodies. These evolving regulations can delay product launches, increase compliance costs, and force reformulations. Additionally, the lack of a universal regulatory definition for probiotics creates market confusion and risks of non-compliance, posing a persistent threat to international expansion strategies and operational stability for manufacturers.

Covid-19 Impact:

The pandemic initially disrupted global supply chains, causing raw material shortages and logistical delays for the probiotic market. However, it simultaneously acted as a powerful catalyst for growth, fueled by a heightened consumer focus on preventive health and immunity. Seeking to bolster their natural defenses, individuals increasingly turned to probiotic supplements, creating a significant demand surge. This period accelerated e-commerce adoption for supplement purchases and embedded gut health deeper into the mainstream wellness conversation, a behavioral shift that continues to positively influence market expansion post-pandemic.

The lactobacillus segment is expected to be the largest during the forecast period

The lactobacillus segment is expected to account for the largest market share during the forecast period attributed to its extensive research history, proven efficacy in addressing common digestive issues like IBS and lactose intolerance, and its widespread incorporation into a diverse range of products, from capsules to fermented foods and beverages. Furthermore, strong consumer familiarity and trust in lactobacillus strains, such as L. acidophilus and L. rhamnosus, solidify its market leadership. Its versatility and established safety profile ensure continued strong demand, making it the foundational genus for both consumers and manufacturers in the probiotic space.

The immune health segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the immune health segment is predicted to witness the highest growth rate driven by a sustained post-pandemic consumer prioritization of immune support. Robust scientific evidence linking a healthy gut microbiome to robust immune function is a key growth driver. Additionally, marketing efforts are increasingly focusing on this scientifically-backed benefit, resonating with a health-conscious global population. This convergence of consumer awareness, clinical validation, and targeted product development creates a powerful growth vector.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share. This leadership is anchored by high consumer health awareness, strong disposable income, and a well-established retail and e-commerce infrastructure for dietary supplements. The presence of major market players and a proactive consumer base that actively seeks out preventive health solutions further consolidates its dominant position. Moreover, while regulatory standards are strict, the region's clear market channels and consumer willingness to invest in premium wellness products ensure its continued revenue dominance.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. This accelerated growth is fueled by a burgeoning middle class with increasing disposable income, rapidly expanding urbanization, and a growing cultural emphasis on preventive healthcare. Additionally, rising awareness of gut health benefits, the influence of traditional fermented foods in local diets, and the aggressive expansion of both international and domestic supplement companies into these emerging markets are key contributors. This dynamic environment makes Asia Pacific the focal point for future market expansion.

Key players in the market

Some of the key players in Probiotic Supplements Market include Chr. Hansen A/S, Probi AB, Yakult Honsha Co., Ltd., Nestle S.A., Danone S.A., International Flavors & Fragrances Inc. (IFF), Lallemand Inc., BioGaia AB, Kerry Group plc, Glanbia plc, NOW Health Group, Inc., Herbalife Nutrition Ltd., Amway Corp., Kemin Industries, Inc., Jarrow Formulas, Inc., Seed Health, Inc., Bio-K Plus International Inc., and GNC Holdings, LLC.

Key Developments:

In June 2025, with rising lifestyle diseases and growing health awareness, India is seeing a clear shift toward proactive healthcare. Aligning with the evolving consumer need, Amway India, a leading company supporting health and wellbeing, strengthened its nutrition category offering with Nutrilite Triple Protect. A scientifically formulated, plant-based supplement powered by the natural strength of Acerola Cherry, Turmeric, and Licorice. This potent formulation has nutrients that offer triple-action benefits-supporting immunity, reducing inflammation, and providing strong antioxidant protection for the gut, skin, and immune health.

In September 2024, Lallemand Health Solutions is spotlighting the benefits of its probiotics offerings for early-life nutrition (ELN) and development. The company touts that its ingredients have been shown to strengthen, promote digestion and bolster babies' natural defenses. At the same time, evidence reveals influences on the gut-brain axis and increased metabolic health.

In June 2023, Nestle Health Science and Seres Therapeutics, Inc. announced that they have signed an agreement in which Nestle Health Science will acquire the VOWST business. Nestle Health Science has been commercializing the VOWST (fecal microbiota spores, live-brpk) capsules since its launch in June 2023 in the United States. This transaction will allow Nestle Health Science full control over the further development, commercialization, and manufacturing of VOWST in the US and worldwide.

Ingredients Covered:

  • Lactobacillus
  • Bifidobacterium
  • Streptococcus Thermophilus
  • Saccharomyces Boulardii
  • Other Strains

Forms Covered:

  • Capsules & Tablets
  • Powder
  • Liquids
  • Gummies & Chewables

Applications Covered:

  • Digestive Health
  • Immune Health
  • Immune Health
  • Oral Health
  • Weight Management
  • Other Applications

End Users Covered:

  • Adults
  • Infants & Children
  • Geriatric Population

Distribution Channels Covered:

  • Hypermarkets/Supermarkets
  • Pharmacies & Drug Stores
  • Specialty Stores
  • Online Retail/E-commerce
  • Direct Sales

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Probiotic Supplements Market, By Ingredient

  • 5.1 Introduction
  • 5.2 Lactobacillus
  • 5.3 Bifidobacterium
  • 5.4 Streptococcus Thermophilus
  • 5.5 Saccharomyces Boulardii
  • 5.6 Other Strains

6 Global Probiotic Supplements Market, By Form

  • 6.1 Introduction
  • 6.2 Capsules & Tablets
  • 6.3 Powder
  • 6.4 Liquids
  • 6.5 Gummies & Chewables

7 Global Probiotic Supplements Market, By Application

  • 7.1 Introduction
  • 7.2 Digestive Health
  • 7.3 Immune Health
  • 7.4 Immune Health
  • 7.5 Oral Health
  • 7.6 Weight Management
  • 7.7 Other Applications

8 Global Probiotic Supplements Market, By End User

  • 8.1 Introduction
  • 8.2 Adults
  • 8.3 Infants & Children
  • 8.4 Geriatric Population

9 Global Probiotic Supplements Market, By Distribution Channel

  • 9.1 Introduction
  • 9.2 Hypermarkets/Supermarkets
  • 9.3 Pharmacies & Drug Stores
  • 9.4 Specialty Stores
  • 9.5 Online Retail/E-commerce
  • 9.6 Direct Sales

10 Global Probiotic Supplements Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Chr. Hansen A/S
  • 12.2 Probi AB
  • 12.3 Yakult Honsha Co., Ltd.
  • 12.4 Nestle S.A.
  • 12.5 Danone S.A.
  • 12.6 International Flavors & Fragrances Inc. (IFF)
  • 12.7 Lallemand Inc.
  • 12.8 BioGaia AB
  • 12.9 Kerry Group plc
  • 12.10 Glanbia plc
  • 12.11 NOW Health Group, Inc.
  • 12.12 Herbalife Nutrition Ltd.
  • 12.13 Amway Corp.
  • 12.14 Kemin Industries, Inc.
  • 12.15 Jarrow Formulas, Inc.
  • 12.16 Seed Health, Inc.
  • 12.17 Bio-K Plus International Inc.
  • 12.18 GNC Holdings, LLC

List of Tables

  • Table 1 Global Probiotic Supplements Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Probiotic Supplements Market Outlook, By Ingredient (2024-2032) ($MN)
  • Table 3 Global Probiotic Supplements Market Outlook, By Lactobacillus (2024-2032) ($MN)
  • Table 4 Global Probiotic Supplements Market Outlook, By Bifidobacterium (2024-2032) ($MN)
  • Table 5 Global Probiotic Supplements Market Outlook, By Streptococcus Thermophilus (2024-2032) ($MN)
  • Table 6 Global Probiotic Supplements Market Outlook, By Saccharomyces Boulardii (2024-2032) ($MN)
  • Table 7 Global Probiotic Supplements Market Outlook, By Other Strains (2024-2032) ($MN)
  • Table 8 Global Probiotic Supplements Market Outlook, By Form (2024-2032) ($MN)
  • Table 9 Global Probiotic Supplements Market Outlook, By Capsules & Tablets (2024-2032) ($MN)
  • Table 10 Global Probiotic Supplements Market Outlook, By Powder (2024-2032) ($MN)
  • Table 11 Global Probiotic Supplements Market Outlook, By Liquids (2024-2032) ($MN)
  • Table 12 Global Probiotic Supplements Market Outlook, By Gummies & Chewables (2024-2032) ($MN)
  • Table 13 Global Probiotic Supplements Market Outlook, By Application (2024-2032) ($MN)
  • Table 14 Global Probiotic Supplements Market Outlook, By Digestive Health (2024-2032) ($MN)
  • Table 15 Global Probiotic Supplements Market Outlook, By Immune Health (2024-2032) ($MN)
  • Table 16 Global Probiotic Supplements Market Outlook, By Oral Health (2024-2032) ($MN)
  • Table 17 Global Probiotic Supplements Market Outlook, By Weight Management (2024-2032) ($MN)
  • Table 18 Global Probiotic Supplements Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 19 Global Probiotic Supplements Market Outlook, By End User (2024-2032) ($MN)
  • Table 20 Global Probiotic Supplements Market Outlook, By Adults (2024-2032) ($MN)
  • Table 21 Global Probiotic Supplements Market Outlook, By Infants & Children (2024-2032) ($MN)
  • Table 22 Global Probiotic Supplements Market Outlook, By Geriatric Population (2024-2032) ($MN)
  • Table 23 Global Probiotic Supplements Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 24 Global Probiotic Supplements Market Outlook, By Hypermarkets/Supermarkets (2024-2032) ($MN)
  • Table 25 Global Probiotic Supplements Market Outlook, By Pharmacies & Drug Stores (2024-2032) ($MN)
  • Table 26 Global Probiotic Supplements Market Outlook, By Specialty Stores (2024-2032) ($MN)
  • Table 27 Global Probiotic Supplements Market Outlook, By Online Retail/E-commerce (2024-2032) ($MN)
  • Table 28 Global Probiotic Supplements Market Outlook, By Direct Sales (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.